UnitedHealth Group Incorporated (NYSE:UNH) is Morse Asset Management Inc's 10th Largest Position

Morse Asset Management Inc lowered its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 5.3% during the first quarter, according to its most recent filing with the SEC. The institutional investor owned 17,007 shares of the healthcare conglomerate's stock after selling 957 shares during the period. UnitedHealth Group accounts for approximately 2.2% of Morse Asset Management Inc's portfolio, making the stock its 10th biggest holding. Morse Asset Management Inc's holdings in UnitedHealth Group were worth $8,907,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in UNH. Marshall & Sterling Wealth Advisors Inc. acquired a new position in shares of UnitedHealth Group in the 4th quarter valued at $26,000. Hurley Capital LLC acquired a new position in shares of UnitedHealth Group in the 4th quarter valued at $28,000. Aster Capital Management DIFC Ltd purchased a new stake in UnitedHealth Group during the 4th quarter worth about $30,000. Kapitalo Investimentos Ltda purchased a new stake in UnitedHealth Group during the 4th quarter worth about $41,000. Finally, Copia Wealth Management purchased a new stake in UnitedHealth Group during the 4th quarter worth about $42,000. Hedge funds and other institutional investors own 87.86% of the company's stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have weighed in on the company. Piper Sandler cut their price target on UnitedHealth Group from $552.00 to $353.00 and set an "overweight" rating on the stock in a report on Tuesday, June 3rd. JPMorgan Chase & Co. increased their price objective on UnitedHealth Group from $405.00 to $418.00 and gave the company an "overweight" rating in a report on Friday, June 20th. Oppenheimer decreased their price objective on UnitedHealth Group from $600.00 to $400.00 and set an "outperform" rating for the company in a research report on Wednesday, May 14th. TD Cowen cut UnitedHealth Group from a "buy" rating to a "hold" rating and set a $308.00 price target for the company. in a report on Monday, May 19th. Finally, Deutsche Bank Aktiengesellschaft reduced their price target on UnitedHealth Group from $521.00 to $362.00 and set a "buy" rating for the company in a report on Wednesday, May 14th. One equities research analyst has rated the stock with a sell rating, nine have assigned a hold rating and fifteen have assigned a buy rating to the stock. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus target price of $394.43.

UnitedHealth Group Price Performance

UNH stock traded up $2.39 during midday trading on Tuesday, hitting $284.53. 11,145,744 shares of the stock were exchanged, compared to its average volume of 7,842,901. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.85 and a current ratio of 0.85. The stock's 50-day moving average price is $304.47 and its 200-day moving average price is $432.39. The stock has a market cap of $258.11 billion, a price-to-earnings ratio of 11.92, a PEG ratio of 1.38 and a beta of 0.45. UnitedHealth Group Incorporated has a fifty-two week low of $248.88 and a fifty-two week high of $630.73.

UnitedHealth Group Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, June 24th. Shareholders of record on Monday, June 16th were given a dividend of $2.21 per share. This is an increase from UnitedHealth Group's previous quarterly dividend of $2.10. The ex-dividend date of this dividend was Monday, June 16th. This represents a $8.84 annualized dividend and a yield of 3.11%. UnitedHealth Group's dividend payout ratio (DPR) is presently 37.02%.

Insider Activity at UnitedHealth Group

In other UnitedHealth Group news, CFO John F. Rex acquired 17,175 shares of the stock in a transaction dated Friday, May 16th. The stock was acquired at an average price of $291.12 per share, with a total value of $4,999,986.00. Following the completion of the transaction, the chief financial officer directly owned 203,796 shares in the company, valued at approximately $59,329,091.52. This trade represents a 9.20% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Kristen Gil acquired 3,700 shares of the stock in a transaction dated Thursday, May 15th. The stock was acquired at an average cost of $271.17 per share, with a total value of $1,003,329.00. Following the transaction, the director owned 3,818 shares of the company's stock, valued at approximately $1,035,327.06. This trade represents a 3,135.59% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have bought a total of 109,408 shares of company stock valued at $31,607,768 in the last ninety days. 0.28% of the stock is owned by insiders.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.